This module provides a comprehensive synthesis of the most impactful clinical and research breakthroughs presented at the 2026 American Academy of Neurology (AAN) Annual Meeting. The curriculum covers a broad spectrum of neurological specialties, including neuroimmunology, epilepsy, movement disorders, and neuroinfectious diseases. Participants will examine late-breaking clinical trial data on novel disease-modifying therapies, such as cell-based interventions for Parkinson’s disease, Fc receptor-targeted treatments for autoimmune conditions, and next-generation antiseizure medications. By focusing on emerging trends—including the growing emphasis on “brain health,” interventional neurology, and mechanism-driven personalized care—this course equips clinicians with the latest evidence to navigate the rapidly evolving therapeutic landscape in neurology.